• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沙丁胺醇RespiClick(™)干粉吸入器治疗哮喘的药代动力学、药效学及临床疗效

Pharmacokinetics, pharmacodynamics, and clinical efficacy of albuterol RespiClick(™) dry-powder inhaler in the treatment of asthma.

作者信息

Welch Michael J

机构信息

a University of California , School of Medicine , San Diego , CA , USA.

b Allergy & Asthma Medical Group & Research Center , San Diego , CA , USA.

出版信息

Expert Opin Drug Metab Toxicol. 2016 Sep;12(9):1109-19. doi: 10.1080/17425255.2016.1209485. Epub 2016 Jul 28.

DOI:10.1080/17425255.2016.1209485
PMID:27424535
Abstract

INTRODUCTION

Incorrect use of inhaler devices by patients with asthma is common and can adversely affect clinical outcomes. Devices that are straightforward to use are less likely to result in dosing errors and can improve patients' satisfaction with therapy and adherence. A novel dry-powder formulation of the rescue bronchodilator albuterol (salbutamol) administered using a multidose dry-powder inhaler (mDPI; RespiClick™) has recently been approved in the USA.

AREAS COVERED

Studies on the albuterol mDPI were identified in searches of PubMed and www.clinicaltrials.gov . Pharmacokinetic, pharmacodynamic, efficacy, and safety data, and patients' experiences with the albuterol mDPI are presented.

EXPERT OPINION

The albuterol mDPI has an efficacy/tolerability profile consistent with other inhaled forms of albuterol, and is reliable, easy to use, and associated with a high level of patient satisfaction. This is the first albuterol dry-powder inhaler (DPI) to become available in the USA, with most other formulations being delivered using a pressurized metered-dose inhaler (pMDI). The availability of a breath-actuated device avoids the challenge of coordinating actuation and breathing when using pMDIs, and could simplify treatment for patients also using a DPI for controller medication. Additional features of RespiClick, such as an integrated dose counter and minimal pre-inhalation preparation, facilitate its use.

摘要

引言

哮喘患者不正确使用吸入装置的情况很常见,这可能会对临床结果产生不利影响。使用简便的装置导致给药错误的可能性较小,并且可以提高患者对治疗的满意度和依从性。一种使用多剂量干粉吸入器(mDPI;RespiClick™)给药的新型急救支气管扩张剂沙丁胺醇(舒喘灵)干粉制剂最近已在美国获得批准。

涵盖领域

通过检索PubMed和www.clinicaltrials.gov确定了关于沙丁胺醇mDPI的研究。本文介绍了其药代动力学、药效学、疗效和安全性数据,以及患者使用沙丁胺醇mDPI的体验。

专家意见

沙丁胺醇mDPI的疗效/耐受性与其他吸入形式的沙丁胺醇一致,可靠、易于使用,并且患者满意度高。这是美国首个上市的沙丁胺醇干粉吸入器(DPI),大多数其他制剂是通过压力定量吸入器(pMDI)给药的。呼吸驱动装置的可用性避免了使用pMDI时协调驱动和呼吸的挑战,并且可以简化同时使用DPI进行控制药物治疗的患者的治疗。RespiClick的其他功能,如集成剂量计数器和最少的吸入前准备,便于其使用。

相似文献

1
Pharmacokinetics, pharmacodynamics, and clinical efficacy of albuterol RespiClick(™) dry-powder inhaler in the treatment of asthma.沙丁胺醇RespiClick(™)干粉吸入器治疗哮喘的药代动力学、药效学及临床疗效
Expert Opin Drug Metab Toxicol. 2016 Sep;12(9):1109-19. doi: 10.1080/17425255.2016.1209485. Epub 2016 Jul 28.
2
Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Albuterol (Salbuterol) Multi-dose Dry-Powder Inhaler and ProAir(®) Hydrofluoroalkane for the Treatment of Persistent Asthma: Results of Two Randomized Double-Blind Studies.沙丁胺醇多剂量干粉吸入器与普米克令舒(ProAir®)氢氟烷烃治疗持续性哮喘的药代动力学、药效学、疗效及安全性:两项随机双盲研究结果
Clin Drug Investig. 2016 Jan;36(1):55-65. doi: 10.1007/s40261-015-0346-y.
3
Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.多剂量干粉吸入器吸入福莫特罗一日两次与定量气雾剂吸入沙丁胺醇一日四次对持续性哮喘患者的疗效、耐受性及哮喘相关生活质量的影响:一项多中心、随机、双盲、双模拟、安慰剂对照的平行组研究。
Clin Ther. 2004 Oct;26(10):1587-98. doi: 10.1016/j.clinthera.2004.10.004.
4
Twelve- and 52-week safety of albuterol multidose dry powder inhaler in patients with persistent asthma.沙丁胺醇多剂量干粉吸入器治疗持续性哮喘患者12周和52周的安全性
J Asthma. 2016;53(2):187-93. doi: 10.3109/02770903.2015.1070862. Epub 2015 Sep 15.
5
A 6-month safety and efficacy study of fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhalers in persistent asthma.丙酸氟替卡松及丙酸氟替卡松/沙美特罗多剂量干粉吸入器用于持续性哮喘的6个月安全性和有效性研究。
Allergy Asthma Proc. 2017 Jul 24;38(4):264-276. doi: 10.2500/aap.2017.38.4061. Epub 2017 May 24.
6
Pilot study of bronchodilator response to inhaled albuterol delivered by metered-dose inhaler and a novel dry powder inhaler.定量气雾剂和新型干粉吸入器吸入沙丁胺醇后支气管扩张反应的初步研究
Ann Allergy Asthma Immunol. 1997 Oct;79(4):322-6. doi: 10.1016/S1081-1206(10)63022-0.
7
Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.丙酸氟替卡松和沙美特罗联合干粉吸入剂(胶囊型和多剂量型)在哮喘和 COPD 患者中的药代动力学和药效学。
J Aerosol Med Pulm Drug Deliv. 2014 Aug;27(4):279-89. doi: 10.1089/jamp.2013.1040. Epub 2013 Sep 28.
8
Pharmacokinetics of fluticasone propionate multidose, inhalation-driven, novel, dry powder inhaler versus a prevailing dry powder inhaler and a metered-dose inhaler.丙酸氟替卡松多剂量、吸入驱动、新型干粉吸入器与现有干粉吸入器及定量气雾剂的药代动力学比较
Allergy Asthma Proc. 2015 Sep-Oct;36(5):365-71. doi: 10.2500/aap.2015.36.3889.
9
Novel albuterol multidose dry powder inhaler in patients with exercise-induced bronchoconstriction: A single-dose, double-blind, randomized, 2-way crossover study.新型沙丁胺醇多剂量干粉吸入器用于运动诱发性支气管收缩患者:一项单剂量、双盲、随机、双向交叉研究。
Respir Med. 2015 Nov;109(11):1410-5. doi: 10.1016/j.rmed.2015.09.004. Epub 2015 Sep 8.
10
Prospective, open-label evaluation of a new albuterol multidose dry powder inhaler with integrated dose counter.一项对带有集成剂量计数器的新型沙丁胺醇多剂量干粉吸入器进行的前瞻性、开放标签评估。
Allergy Asthma Proc. 2016 May;37(3):199-206. doi: 10.2500/aap.2016.37.3938. Epub 2016 Jan 29.

引用本文的文献

1
Salbutamol in the Management of Asthma: A Review.沙丁胺醇在哮喘管理中的应用:综述。
Int J Mol Sci. 2022 Nov 17;23(22):14207. doi: 10.3390/ijms232214207.
2
Determining the optimal time to assess the reversibility of airway obstruction.确定评估气道阻塞可逆性的最佳时间。
Lung India. 2019 Mar-Apr;36(2):123-130. doi: 10.4103/lungindia.lungindia_184_18.